Spotlight on Memorial Sloan-Kettering's Young Faculty
Many of Memorial Sloan-Kettering's advances in patient care, research, and education are made by young staff members who are just beginning their careers.
Pediatric Patient Story - Victoria White
Life as the White family knew it changed forever on November 14, 2005, the day their daughter Victoria was diagnosed with Wilms' tumor. Having survived the day and its aftermath, which was marked by Victoria's courage and tenacious effervescence, they now consider November 14 their own Veterans Day.
New Bladder Cancer Prediction Tool
This tool, known as a nomogram, can be used to calculate the risk of bladder cancer recurrence five years after radical cystectomy. It is designed to assess the risk estimate for individual patients, which is a key factor in deciding whether adjuvant treatment -- typically systemic chemotherapy -- is likely to be beneficial.
Study Shows No Benefit for CT Screening for Lung Cancer
The first report of an international study looking at computed tomography (CT) to screen current or former smokers for lung cancer found that screening did not reduce deaths from lung cancer. Although CT screening found nearly three times as many lung cancers as predicted, the researchers found that early detection and treatment did not lead to a corresponding decrease in advanced lung cancers or a reduction in deaths from lung cancer. The multi-center study, led by researchers at Memorial Sloan-Kettering, found no advantage to using CT screening on current or former smokers -- the population at highest risk for developing lung cancer.
Patient-reported Side Effects Can Add Value to Clinical Studies
A study by a team of Memorial Sloan-Kettering Cancer Center clinicians has suggested that asking patients to report side effects during cancer treatment could add valuable information to the monitoring and early detection of potentially serious problems, especially during clinical trials.
Evidence Suggests Mad2 Gene May Help Initiate Cancer
A team of scientists led by Memorial Sloan-Kettering cancer biologist Robert Benezra has revealed new insights into the mechanism of tumor formation by boosting levels of the Mad2 gene in mice.
CancerSmart Webcast: An Update on Genetic Testing and Cancer Risk Counseling
Watch as experts from Memorial Sloan-Kettering's Clinical Genetics Service -- Kenneth Offit, MD, and Karen E. Hurley, PhD -- provide an overview of genetic testing and cancer risk counseling. Topics include: breast and colon cancer genetics, psychological aspects, and ethical issues.
